Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 8, 2003, Pages 4909-4914

  Fitch, Richard W ^a   Xiao, Yingxian ^b   Kellar, Kenneth J ^b   Daly, John W ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; CYTISINE; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; MECAMYLAMINE; NEUROMUSCULAR RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CALCIUM SIGNALING; CELL LINE; CONTROLLED STUDY; DEPOLARIZATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MEMBRANE POTENTIAL FLUORESCENCE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; CALCIUM SIGNALING; CELL LINE; CHOLINERGIC AGENTS; FLUORESCENT DYES; HUMANS; MEMBRANE POTENTIALS; NICOTINIC ANTAGONISTS; RATS; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; TRANSFECTION;

ILEX COOKII;

EID: 0344490327     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0630641100     Document Type: Article

References (41)

1. Lukas, R. J., Changeux, J.-P., LeNovère, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) Pharmacol. Rev. 51, 397-401.
2. Lindstrom, J. (2000) Handb. Exp. Pharmacol. 144, 101-162.
3. Dani, J. A. (2001) Biol. Psychiatry 49, 166-174.
4. Holladay, M. W., Dart., J. & Lynch, J. K. (1997) J. Med. Chem. 40, 4169-4194.
5. Decker, M. W., Meyer, M. D. & Sullivan, J. P., (2001) Exp. Opin. Invest. Drugs 10, 1819-1830.
6. Lloyd, G. K. & Williams, M. (2000) J. Pharmacol. Exp. Ther. 292, 461-467.
7. Schmidt, J. D. & Bencherif, M. (2000) Annu. Rep., Med. Chem. 35, 41-51.
8. Lukas, R. J, (1986) J. Neurochem. 46, 1936-1941.
9. Gotti, C., Wanke, E., Sher, E., Fornasari, D., Cabrini, D & Clementi, F. (1986) Biochem. Biophys. Res. Commun. 137, 1141-1147.
10. Houghtling, R. A., Davila-Garcia, M. I. & Kellar, K. J. (1995) Mol. Pharmacol. 48, 280-287.
11. Davies, A. R. L, Hardick, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J. & Wonnacott, S. (1999) Neuropharmacology 38, 679-690.
12. Connolly, J. C. & Kennedy, C. (1998) Drugs Pharm. Sci. 89, 107-133.
13. Bertrand, D., Buissand, B., Krause, R. M., Hu, H. Y. & Bertrand, S. (1997) J. Recept. Sig. Transd. Res. 17, 227-242.
14. Catterall, W. A. (1974) J. Biol. Chem. 250, 1776-1781.
15. Lukas, R. J. & Cullen, M. J. (1988) Anal. Biochem. 175, 212-218.
16. Villarroya, M., López, M. G., Cano-Abad, M. F. & Garcia, A. G. (1999) Methods Mol. Biol. 114, 137-147.
17. Veliçelebi, G., Stauderman, K. A., Varney, M. A., Akong, M., Hess, S. D. & Johnson, E. C. (1999) Methods Enzymol. 279, 20-47.
18. Chavez-Noriega, L. E., Gillespie, A., Stauderman, K. A., Crona, J. H., O'Neil Claeps, B., Elliott, K. J., Reid, R. T., Rao, T. S., Veliçelebi, G., Harpold, M. M., et al. (2000) Neuropharmacology 39, 2543-2560.
19. Manning, T. J., Jr., & Sontheimer, H. (1999) J. Neurosci. Methods 91, 73-81.
20. Kuntzweiler, T. A., Arneric, S. P. & Donnelly-Roberts, D. L. (1998) Drug Dev. Res. 44, 14-20.
21. Whiteaker, K. L., Gopalakrishnan, S. M., Groebe, D., Sheih, C. C., Warrior, U., Burns, D. J., Coghlan, M. J., Scott, V. E. & Gopalakrishnan, M. (2001) J. Biomol. Screen 6, 305-312.
22. Baxter, D. F., Kirk, M., Garcia, A. F., Raimondi, A., Holmqvist, M. H., Flint, K. K., Bojanic, D., Distefano, P. S., Curtis, R. & Xie, Y. (2002)J. Biomol. Screen 7, 79-85.
23. Lukas, R. J. (1986) J. Pharmacol. Exp. Ther. 265, 294-302.
24. Lukas, R., Norman, S. & Lucero, L. (1993) Mol. Cell. Neurosci. 4, 1-12.
25. Xiao, Y., Meyer, E. L., Thompson, J. M., Surin, A., Wroblewski, J. & Kellar, K. J. (1996) Mol. Pharmacol. 54, 322-333.
26. Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P. & Sullivan, J. P. (1996) J. Pharmacol. Exp. Ther. 276, 289-297.
27. Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W. & Lester, R. A. J. (1997) J. Neurosci. 17, 5747-5759.
28. Marks, M. J., Robinson, S. F. & Collins, A. C. (1996) J. Pharmacol. Exp. Ther. 277, 1383-1396.
29. Zhang, J., Xiao, Y., Abrakhamanova, G., Wang, W., Cleeman, L., Kellar, K. J. & Morad, M. (1999) Mol. Pharmacol. 55, 970-981.
30. Meyer, E. L., Xiao, Y. & Kellar, K. J. (2001) Mol. Pharmacol. 60, 568-576.
31. Krahn, T., Paffhausen, W., Schade, A., Bechem, M. & Schmidt, D. (2002) U.S. Patent 6,420,183; (2002) Chem. Abstr. 128, 59162.
32. Teicher, B. A. (1999) in Human Cell Culture, eds. Masters, J. R. W. & Palsson, B. (Kluwer, New York), Vol. 1, pp. 1-19.
33. Tumilowicz, J. J., Nichols, W. W., Cholon, J. J. & Greene, A. E. (1970) Cancer Res. 30, 2110-2118.
34. Clementi, F., Cabrini, D., Gotti, C. & Sher, E. (1986) J. Neurochem. 47, 291-297.
35. Nelson, M. E., Wang, F., Kuryatov, A., Choi, D. H., Gersanich, V. & Lindstrom, J. (2001) J. Gen. Physiol. 118, 563-582.
36. Ross, R. A., Spengler, B. A. & Biedler, J. L. (1983) J. Natl. Cancer Inst. 71, 741-749.
37. Warpman, U., Friberg, L., Gillespie, A., Hellström-Lindahl, E., Zhang, X. & Nordberg, A. (1998) J. Neurochem. 70, 2028-2036.
38. Theile, C. J. (1999) in Human Cell Culture, eds. Masters, J. R. W. & Palsson, B. (Kluwer, New York), Vol. 1, pp. 21-53.
39. Minta, A., Kao, J. P. & Tsien, R. Y. (1989) J. Biol. Chem. 264, 8171-8178.
40. Grynkiewicz, G., Poenie, M. & Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450.
41. Gee, K. R., Brown, K. A., Chen, W. N. U., Bishop-Stewart, J., Gray, D. & Johnson, I. (2000) Cell Calcium 27, 97-106.